
ZIMMER BIOMET HOLDINGS INC
ZBHNYSETrading Snapshot
- Day Range
- $441.63 β $455.48
- 52-Week Range
- $79.12 β $108.29
- Volume
- $2.47B
- Avg Volume
- $3.06B
- Shares Outstanding
- 193.5M
- Next Earnings
- Sep 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $8.23B
- Last Q Revenue
- $2.18B
- P/E Ratio
- 23.1
- P/S Ratio
- 2.2x
- EPS (TTM)
- $4.11
- Dividend Yield
- 1.01%
Why Investors Own ZBH
- βHigh-growth profile β revenue up -5.3% YoY with expanding US Equity exposure.
- βHealthy economics β 76% gross margin and 20% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ZIMMER BIOMET HOLDINGS INC
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
ZIMMER BIOMET HOLDINGS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ZBH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ZIMMER BIOMET HOLDINGS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.